Programmable Release of Multiple Protein Drugs from Aptamer-Functionalized Hydrogels via Nucleic Acid Hybridization
- 24 July 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 134 (30) , 12410-12413
Abstract
Polymeric delivery systems have been extensively studied to achieve localized and controlled release of protein drugs. However, it is still challenging to control the release of multiple protein drugs in distinct stages according to the progress of disease or treatment. This study successfully demonstrates that multiple protein drugs can be released from aptamer-functionalized hydrogels with adjustable release rates at predetermined time points using complementary sequences (CSs) as biomolecular triggers. Because both aptamer–protein interactions and aptamer–CS hybridization are sequence-specific, aptamer-functionalized hydrogels constitute a promising polymeric delivery system for the programmable release of multiple protein drugs to treat complex human diseases.Keywords
This publication has 39 references indexed in Scilit:
- Tunable Growth Factor Delivery from Injectable Hydrogels for Tissue EngineeringJournal of the American Chemical Society, 2011
- Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4Journal of Clinical Oncology, 2006
- Designing materials for biology and medicineNature, 2004
- Repair of bone defects using synthetic mimetics of collagenous extracellular matricesNature Biotechnology, 2003
- Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralizationJournal of Controlled Release, 2002
- Polymeric system for dual growth factor deliveryNature Biotechnology, 2001
- Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation studyJACC, 2000
- Hydrogels in pharmaceutical formulationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Development of fibrin derivatives for controlled release of heparin-binding growth factorsJournal of Controlled Release, 2000
- Side Effects Resulting From the Use of Growth Hormone and Insulin-like Growth Factor-I as Combined Therapy to Frail Elderly PatientsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 1998